11th Drug Discovery Strategic Summit

November 10th -11th, 2022, Amsterdam, Netherlands

Redefining Your Conference Experience with Excellence!

About The Event

AFSG is delighted to announce the 11th Drug Discovery Strategic Summit (DDSS), in November 10th-11th, 2022, Amsterdam, Netherlands for the two-days of insightful and exciting business development opportunity. This year’s DDSS like our previous summits is packed with great talks from industry top speakers, panel discussion among thought leaders, poster sessions, prescheduled meetings and ground breaking research presentations overcoming the challenges and avenues in drug discovery. Explore our website to learn how all of this and more redefines your networking experience and ensures that you get the maximum out of your time and investment with us.

Main Focus of The Event

Growing The Industry

Industry Thought Leaders Discussing the Challenges of the Market.

Connecting The People

A See-Suite only, designed to help you make connections that matters.

“I would definitely recommend your interesting summit to other people specially people working in small and mid-size companies. I would say that quality of summit was very good because, we had very interesting talks with all the delegates we met. Same goes for prequalified one-to-one meetings protocol.”

Astorgues Xerrs

Preclinical Project Manager of Afr Oncology

Our Exclusive Meeting Protocol Guarantees a Higher Chance of Cutting the Deal on Spot!

Audience Stats at 11th DDSS

Key Talks You Shouldn’t Miss

Meet the world’s leading drug discovery, development, and data analytics experts
and thought leaders in Amsterdam.

Willem Jespers

Assistant Professor AI & Structure-Based Drug Discovery at University Leiden

Hayley Binch

Head of Medicinal Chemistry at Roche

Alex Macpherson

Senior Principal scientist at UCB

Sebastian Nijman

Founder and Chief Scientific Officer at Scenic Biotech

Mark Krul

Director at Aglaia Oncology Funds

Dr. Jonathan Ward

CEO and Co-Founder

Joachim Pfeifer

Scientific Director at Amgen

Greg Osborne

Director Pharmacology at Sosei Heptares

Matthias Frech

Director Molecular Interactions and Biophysics

David Moreno

Associate Director Early drug discovery

Dilyana Dimova

Senior Data Scientist at Sanofi

Robert Soliva

Head of Drug Discovery at Oryzon Genomics

Jack Gallagher


Marcel Van Duin

VP Head of External Innovation & Emerging Science At Organon

Roel Arends

Senior Principal Scientist at Byondis BV

Renee Aguiar-Lucander

CEO at Calliditas Therapuetics

Pedro Madureira

Co-founder and CSO at Immunethep

Andreas Bender

Chief Technology and informatics Officer at Pangea Botanical

Michael Thormann

Co-Founder and Managing Director at Origenis

Avinash Patel

Senior Director, Head Exploratory Condensate Science at Dewpoint Therapeutics

Dr. Patrizia A d'Alessio

CEO at Aisa Therapeutics

Dr. Krzysztof B Wicher

VP, Head of Drug Discovery at Macomics

Our Partners

Our venue

Event Headlines

Our aim is to deliver personalized, integrated and measurable conferences that address the unique requirements and goals of our clients. Agile Falcon (AF) Strategic Group conferences get the right requirement to the right audience at the right time.

Keynote Presentations

100+ Attendees

Panel Discussions

One-to-One Meetings

What Our Clients Say About us

Take our word for it, or hear what your peers have to say about us

Subscribe to Our Newsletter

Don't miss new updates on your email